Quality & Patient Safety

China’s regulators act fast after drug suspected in six patient deaths

Patient Safety Monitor: Global Edition, June 10, 2008

After previous promises to tighten up regulation of its pharmaceutical industry, Chinese regulators promptly reacted after six patients who received a blood-based drug at a Jiangxi province hospital, reports the International Herald Tribune.

All six patients were treated with the same batch of human immunoglobulin. Regulators swiftly made efforts to remove any remainders of the bad drug batch.

To read more, click here.

Comments

0 comments on “China’s regulators act fast after drug suspected in six patient deaths

 

    Patient Safety Monitor
  • Patient Safety Monitor

    As part of your Patient Safety Monitor membership, you'll receive Briefings on Patient Safety. In this 12-page monthly...

  • Patient Safety Monitor Alert

    This e-mail newsletter provides healthcare professionals with the latest patient safety news, while offering useful...

  • Patient Safety Quality Monthly

    Ken Rohde, Senior Consultant for The Greeley Company with over 25 years of experience in quality management. His roles in...

  • Occurrence Reporting:

    Take advantage of the information occurrence reports provide and make sustainable enhancements at your facility. Expert...

Most Popular

Related Articles